Dambkowski Carl bought APGE
July 2, 2025 · Form 4 insider transaction
Dambkowski Carl bought 7,365 shares of Apogee Therapeutics Inc at $22.86 per share, a transaction worth $168.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,365
Price
$22.86
Total value
$168.4K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 2, 2025
Filing dateJuly 3, 2025
Shares owned after249,088
OwnershipDirect
10b5-1 planNo
AmendedNo